European Society for Blood and Marrow Transplantation

European Society for Blood and Marrow Transplantation
Name	European Society for Blood and Marrow Transplantation
Formation	1974
Type	Professional society
Headquarters	Leiden, Netherlands
Leader title	President

European Society for Blood and Marrow Transplantation is a professional association dedicated to hematopoietic stem cell transplantation and cellular therapy, linking experts across Europe, North America, Asia, Africa, and Oceania to improve patient outcomes, research, and clinical practice. The society collaborates with healthcare institutions, regulatory bodies, and charitable organizations such as World Health Organization, European Commission, European Medicines Agency, National Institutes of Health, and American Society of Hematology to promote standards, data sharing, and training in transplant medicine.

History

Founded in 1974 by clinicians and researchers influenced by developments at centres like Fred Hutchinson Cancer Center, Karolinska University Hospital, St Bartholomew's Hospital, Institut Gustave Roussy, and Royal Free Hospital, the society arose amid advances in bone marrow transplantation, immunology, and oncology. Early contributors included teams associated with Niels Bohr Institute-era collaborations, investigators from Memorial Sloan Kettering Cancer Center, and groups linked to trials at Mayo Clinic and University of Minnesota Medical School. Through the 1980s and 1990s the organization expanded alongside milestones such as the introduction of peripheral blood stem cell transplantation at Johns Hopkins Hospital, development of reduced-intensity conditioning protocols investigated at MD Anderson Cancer Center, and the recognition of graft-versus-host disease mechanisms described by researchers connected to Karolinska Institutet and University of Oxford. Partnerships with patient advocacy groups like Leukemia & Lymphoma Society and networks including European Organisation for Research and Treatment of Cancer spurred multinational registries and collaborative trials.

Mission and Activities

The society's mission emphasizes improving survival and quality of life for patients with hematologic malignancies, inherited marrow failure syndromes, and immune deficiencies through evidence-based transplantation and cellular therapies developed with institutions such as Cleveland Clinic, University College London Hospitals, Charité – Universitätsmedizin Berlin, and Hospices Civils de Lyon. It facilitates multicentre studies involving groups like European LeukemiaNet, promotes harmonization with regulatory frameworks from Council of Europe and European Parliament, and supports translational research bridging laboratories at Wellcome Trust Sanger Institute, Institut Pasteur, and Max Planck Society with clinical centres.

Organizational Structure

Governance is typically executed via an elected executive committee, scientific council, and regional working parties that coordinate with national societies including British Society for Haematology, German Society for Hematology and Medical Oncology, French Society of Hematology, and Italian Society of Hematology. Institutional partners and donor foundations such as Bill & Melinda Gates Foundation, European Research Council, and philanthropic arms of hospitals participate in advisory roles. The society interfaces with professional networks like International Society for Heart and Lung Transplantation for cross-disciplinary exchange and with accreditation bodies linked to Joint Commission International.

Membership and Committees

Membership encompasses clinicians, scientists, allied health professionals, and trainees from centres such as Hospital Clínic de Barcelona, Sahlgrenska University Hospital, University Hospital Zurich, and Rigshospitalet. Committees include the Stem Cell Transplantation Committee, Pediatric Working Party, Infectious Diseases Working Party, and Cellular Therapy & Immunobiology Working Party, which coordinate guidelines and trials in collaboration with groups like European Society of Medical Oncology and Pediatric Oncology Group affiliates.

Research, Data and Registry

A central activity is maintaining large-scale registries modeling systems like Surveillance, Epidemiology, and End Results Program and national transplant databases at Agence de la Biomédecine, enabling outcome analyses for allogeneic and autologous transplants, cord blood banking studies linked to Netcord-FACT, and chimerism research with laboratories at Broad Institute. Registry outputs inform randomized trials conducted in partnership with cooperative groups such as Children's Oncology Group and meta-analyses published alongside collaborators from Cochrane Collaboration. Data governance aligns with standards set by General Data Protection Regulation and ethics panels connected to European Society for Medical Oncology review boards.

Education, Guidelines and Accreditation

Educational programs include summer schools, fellowship exchanges, and certification pathways comparable to curricula at European Board of Haematology and training models used by Royal College of Physicians. The society issues clinical practice guidelines, consensus statements, and accreditation criteria coordinated with FACT-JACIE and national competent authorities, addressing antimicrobial prophylaxis developed with European Centre for Disease Prevention and Control, conditioning regimens informed by trials at Dana-Farber Cancer Institute, and cellular therapy standards paralleling guidance from International Society for Cellular Therapy.

Conferences and Publications

Annual congresses bring together speakers from universities and hospitals including University of Cambridge, Imperial College London, Heidelberg University Hospital, and University of Milan, and attract participation from pharmaceutical and biotech firms such as Novartis, Roche, and Gilead Sciences presenting translational data. The society publishes peer-reviewed guidelines, position papers, and registry reports in collaboration with journals and publishers affiliated with Lancet Oncology, New England Journal of Medicine, Blood (journal), and Journal of Clinical Oncology, and supports open educational resources with partners such as World Federation of Hemophilia.

Category:Medical associations